Australian research shows genetic discrimination by insurers undermines public trust in medical research and biobanks.

Australian research reveals genetic discrimination by insurance companies erodes public trust in medical research and biobanks. Despite general support for genomic research, concerns about unfair insurance practices and data selling hinder trust. A national biobank managed by public institutions is preferred over commercial involvement. Legislation preventing genetic discrimination could help build trust and encourage genomic data donation.